Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer
Launched by SHANDONG PROVINCIAL HOSPITAL · Sep 29, 2024
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the amount of iodine in a person's diet might affect thyroid cancer. Researchers want to understand if different levels of iodine in various regions are linked to the types of thyroid cancer people develop, their symptoms, and how well they respond to treatment. The study is currently recruiting participants who have had thyroid surgery for cancer between 2012 and 2019.
To be eligible for this study, participants should be between 18 and 65 years old, have lived in the study area for at least five years, and have a confirmed diagnosis of thyroid cancer after surgery. They should also have complete medical records available for review. Participants can expect to be followed for their health outcomes after their surgery, helping doctors understand more about the relationship between iodine levels and thyroid cancer. It's important to note that individuals with other types of cancer or serious health issues, like heart or kidney disease, will not be included in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age range: 18\~65 years old, gender not limited;
- • 2. Living in the selected region for at least 5 years;
- • 3. Patients who underwent thyroid surgery at various research centers were pathologically diagnosed with thyroid cancer;
- • 4. The clinical data (general information、surgical scope 、pathological report、utrasonic report, etc )of the case is complete.
- Exclusion Criteria:
- • 1. Diagnosed as other types of cancer or thyroid metastatic cancer;
- • 2. There are serious comorbidities such as heart, liver, and kidney diseases present;
- • 3. Unable to follow up on prognostic information.
About Shandong Provincial Hospital
Shandong Provincial Hospital is a leading medical institution located in Jinan, China, renowned for its commitment to advancing healthcare through innovative clinical research. As a prominent sponsor of clinical trials, the hospital focuses on enhancing patient care and therapeutic outcomes across various medical disciplines. With a multidisciplinary team of experienced healthcare professionals and researchers, Shandong Provincial Hospital emphasizes rigorous scientific methodology, ethical standards, and patient safety in its clinical research initiatives. The hospital's state-of-the-art facilities and collaborative environment foster the development of groundbreaking treatments, ultimately contributing to the global medical community's knowledge and practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported